Incyte (Nasdaq:INCY) has updated its presentation time at the following investor conference: JMP Securities Hematology & Oncology Forum (Virtual) on Thursday, June 18, 2020, now at 3:00 p.m. (EDT). The presentation at the BMO Prescriptions for Success Healthcare Conference (Virtual) on Tuesday, June 23, 2020 at 1:30 p.m. (EDT) is unchanged. The presentations for both conferences will be webcast
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) has updated its presentation time at the following investor conference:
- JMP Securities Hematology & Oncology Forum (Virtual) on Thursday, June 18, 2020, now at 3:00 p.m. (EDT).
The presentation at the BMO Prescriptions for Success Healthcare Conference (Virtual) on Tuesday, June 23, 2020 at 1:30 p.m. (EDT) is unchanged.
The presentations for both conferences will be webcast live and can be accessed at Investor.Incyte.com. Replays will be available for 30 days.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200617005085/en/
Contacts
Media
Catalina Loveman, +1 302 498 6171
cloveman@incyte.com
Investors
Michael Booth, DPhil, +1 302 498 5914
mbooth@incyte.com
Source: Incyte
View this news release online at:
http://www.businesswire.com/news/home/20200617005085/en
